Product
3BNC117
1 clinical trial
1 indication
Indication
HIV-1 infectionClinical trial
Combining a TLR9 Agonist With Broadly Neutralizing Antibodies for Reservoir Reduction and Immunological Control of HIV Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial.Status: Completed, Estimated PCD: 2022-07-01